Index of reports
> Disability (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Elidel (Pimecrolimus) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Elidel side effects in male
Reported by a physician from United States on 2012-07-24
Patient: male
Reactions: Anion GAP Increased, Chapped Lips, Blood Albumin Decreased, Burkitt's Lymphoma Stage II, White Blood Cell Count Increased, Blood Alkaline Phosphatase Decreased, Hypotension, Small Intestinal Obstruction, Blood Phosphorus Decreased, Aspartate Aminotransferase Increased, Epstein-Barr Virus Test Positive, Atelectasis, Blood Magnesium Decreased, Constipation, Electrolyte Depletion, Somnolence, Blood Calcium Decreased, Haematocrit Decreased, RED Blood Cell Count Decreased, Blood Uric Acid Increased, Pleural Effusion, Blood Sodium Decreased, Blood Glucose Increased, Intussusception, Nausea, LIP DRY, Blood Chloride Decreased, Febrile Neutropenia, Protein Total Decreased, Ascites, Immunosuppressant Drug Level Decreased, Renal Failure, Blood Potassium Decreased, Sepsis, Heart Rate Increased, Carbon Dioxide Decreased, Alanine Aminotransferase Decreased, Hypertension
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Elidel
Dosage: (df topical)
Administration route: Topical
Indication: Dermatitis Atopic
Imuran
Dosage: (50 mg qd)
Indication: Product Used FOR Unknown Indication
Prograf
Dosage: (2 mg bid)
Indication: Product Used FOR Unknown Indication
Singulair
Dosage: ( 4 mg 4d)
Indication: Multiple Allergies
Other drugs received by patient: Sodium Chloride; Izofran / 00955301 /; Ventolin HFA; Aloprim; Protonix; Valium; Hydromorphone Hydrochloride; Dilaudid; Nubain; Narcan; D-51 / 2 NS + KCL; Mefoxin
|